ROIV - Roivant Sciences Ltd. Common Shares -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Roivant Sciences Ltd. Common Shares
IPO Date: January 1, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $25.1B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.33 | 2.85%
Avg Daily Range (30 D): $0.79 | 2.12%
Avg Daily Range (90 D): $0.73 | 2.11%
Institutional Daily Volume
Avg Daily Volume: 3.72M
Avg Daily Volume (30 D): 5.86M
Avg Daily Volume (90 D): 4.79M
Trade Size
Avg Trade Size (Sh.): 132
Avg Trade Size (Sh.) (30 D): 87
Avg Trade Size (Sh.) (90 D): 84
Institutional Trades
Total Institutional Trades: 5,319
Avg Institutional Trade: $4.88M
Avg Institutional Trade (30 D): $8.63M
Avg Institutional Trade (90 D): $7.29M
Avg Institutional Trade Volume: .28M
Avg Institutional Trades (Per Day): 5
Market Closing Trades
Avg Closing Trade: $15.2M
Avg Closing Trade (30 D): $86.68M
Avg Closing Trade (90 D): $52.54M
Avg Closing Volume: 877.56K
 
News
Sep 9, 2026 @ 11:15 AM
Company News for Sep 9, 2026
Source: Na
Sep 8, 2026 @ 12:00 PM
Dr. Gillian Cannon Joins Lindus Therapeuticsâ€â...
Source: Na
May 18, 2026 @ 5:00 PM
Myasthenia Gravis Market Set to Surpass USD 16 Bil...
Source: Delveinsight
Apr 15, 2026 @ 5:00 PM
Generalized Myasthenia Gravis Market on the Brink ...
Source: Delveinsight
Apr 2, 2026 @ 9:00 AM
Priovant Expands Brepocitinib Development Program ...
Source: Na
Financials
  TTM Q1 2027 Q4 2026
Basic EPS $-.36 $-.26 $.45
Diluted EPS $-.47 $-.26 $.34
Revenue $7.53M $1.44M $2.52M
Gross Profit
Net Income / Loss $-414.6M $-290.61M $355.74M
Operating Income / Loss $-596.14M $-365.99M $415.24M
Cost of Revenue
Net Cash Flow $8.67M $-170.75M $-59.1M
PE Ratio